Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
8
×
fda
8
×
life sciences
national blog main
clinical trials
boston blog main
national top stories
amgen
boston top stories
eli lilly
new york blog main
san francisco blog main
deals
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
new york top stories
novartis
san francisco top stories
boston
boulder/denver blog main
boulder/denver top stories
calcitonin gene-related peptide
chronic migraine
episodic migraine
europe blog main
investing
migraine
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
teva pharmaceutical
texas blog main
texas top stories
wisconsin blog main
What
fda
8
×
medicines
8
×
drug
new
approved
approval
class
migraine
nod
wins
cholesterol
developed
developing
ipo
pain
pill
regulatory
starts
therapeutics
treat
won
acquire
activity
adults
affects
agreed
allergan
americans
amgen
announced
approvals
billion
bio
biogen
blueprint
brings
cancer
candidate
candidates
cash
Language
unset
Current search:
fda
×
biotech
×
medicines
×
fda
×
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Esperion’s Combo Pill for Lowering Cholesterol Levels Wins FDA Nod
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines
@xconomy.com
5 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines